The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS

Keerie, A., Brown-Wright, H., Kirkland, I. et al. (4 more authors) (2021) The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS. Scientific Reports, 11. 17027. ISSN 2045-2322

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2021. Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Dates:
  • Accepted: 9 August 2021
  • Published (online): 23 August 2021
  • Published: 23 August 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
Motor Neurone Disease AssociationMNDA-SITraN/Jul16/987-797
Depositing User: Symplectic Sheffield
Date Deposited: 01 Sep 2021 13:48
Last Modified: 01 Sep 2021 13:48
Status: Published
Publisher: Nature Research
Refereed: Yes
Identification Number: https://doi.org/10.1038/s41598-021-96418-0

Share / Export

Statistics